These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31830030)

  • 1. Predicting and designing therapeutics against the Nipah virus.
    Sen N; Kanitkar TR; Roy AA; Soni N; Amritkar K; Supekar S; Nair S; Singh G; Madhusudhan MS
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007419. PubMed ID: 31830030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-step molecular docking and dynamics simulation-based screening of large antiviral specific chemical libraries for identification of Nipah virus glycoprotein inhibitors.
    Kalbhor MS; Bhowmick S; Alanazi AM; Patil PC; Islam MA
    Biophys Chem; 2021 Mar; 270():106537. PubMed ID: 33450550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput virtual screening of Streptomyces spp. metabolites as antiviral inhibitors against the Nipah virus matrix protein.
    Macalalad MAB; Odchimar NMO; Orosco FL
    Comput Biol Chem; 2024 Oct; 112():108133. PubMed ID: 38968780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the interaction between potent small molecules against the Nipah virus Glycoprotein in Malaysia and Bangladesh strains, accompanied by the human Ephrin-B2 and Ephrin-B3 receptors; a simulation approach.
    Ebrahimi M; Alijanianzadeh M
    Mol Divers; 2024 Apr; 28(2):851-874. PubMed ID: 36808582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A top-down approach for studying the in-silico effect of the novel phytocompound tribulusamide B on the inhibition of Nipah virus transmission through targeting fusion glycoprotein and matrix protein.
    Rababi D; Nag A
    Comput Biol Chem; 2024 Oct; 112():108135. PubMed ID: 38944906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
    Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
    J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion.
    Rodriguez JJ; Cruz CD; Horvath CM
    J Virol; 2004 May; 78(10):5358-67. PubMed ID: 15113915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.
    Pallister J; Middleton D; Crameri G; Yamada M; Klein R; Hancock TJ; Foord A; Shiell B; Michalski W; Broder CC; Wang LF
    J Virol; 2009 Nov; 83(22):11979-82. PubMed ID: 19759137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review.
    Bhattacharya S; Dhar S; Banerjee A; Ray S
    Curr Mol Pharmacol; 2020; 13(2):108-125. PubMed ID: 31657692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
    Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
    J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening.
    Lo MK; Nichol ST; Spiropoulou CF
    Antiviral Res; 2014 Jun; 106():53-60. PubMed ID: 24680955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking and dynamics studies for the identification of Nipah virus glycoprotein inhibitors from Indian medicinal plants.
    Abhinand CS; Ibrahim J; Keshava Prasad TS; Raju R; Oommen OV; Nair AS
    J Biomol Struct Dyn; 2023 Nov; 41(19):9211-9218. PubMed ID: 36473711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome Based Approach Defines Candidates for Designing a Multitope Vaccine against the Nipah Virus.
    Soltan MA; Eldeen MA; Elbassiouny N; Mohamed I; El-Damasy DA; Fayad E; Abu Ali OA; Raafat N; Eid RA; Al-Karmalawy AA
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of two conserved G-quadruplex forming motifs in the Nipah virus genome and their interaction with G-quadruplex specific ligands.
    Majee P; Kumar Mishra S; Pandya N; Shankar U; Pasadi S; Muniyappa K; Nayak D; Kumar A
    Sci Rep; 2020 Jan; 10(1):1477. PubMed ID: 32001794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational identification of drug-like marine natural products as potential RNA polymerase inhibitors against Nipah virus.
    Abduljalil JM; Elfiky AA; Sayed ETA; AlKhazindar MM
    Comput Biol Chem; 2023 Jun; 104():107850. PubMed ID: 36907056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
    Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
    Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic investigation of Nipah virus surface protein mutations: Molecular docking with Ephrin B2 receptor, molecular dynamics simulation, and structural impact analysis.
    Aktaş E; Saygılı İ; Kahveci E; Tekbıyık Z; Özgentürk NÖ
    Microbiol Immunol; 2023 Dec; 67(12):501-513. PubMed ID: 37812043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Human-Nipah Virus Protein-Protein Interactome.
    Martinez-Gil L; Vera-Velasco NM; Mingarro I
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro.
    Aljofan M; Sganga ML; Lo MK; Rootes CL; Porotto M; Meyer AG; Saubern S; Moscona A; Mungall BA
    Virol J; 2009 Nov; 6():187. PubMed ID: 19889218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential novel inhibitors against emerging zoonotic pathogen
    Ropón-Palacios G; Chenet-Zuta ME; Olivos-Ramirez GE; Otazu K; Acurio-Saavedra J; Camps I
    J Biomol Struct Dyn; 2020 Jul; 38(11):3225-3234. PubMed ID: 31411538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.